Literature DB >> 20173133

Right ventricular involvement in acute left ventricular myocardial infarction: prognostic implications of MRI findings.

Christoph J Jensen1, Markus Jochims, Peter Hunold, Georg V Sabin, Thomas Schlosser, Oliver Bruder.   

Abstract

OBJECTIVE: The purpose of this study was to investigate the prevalence and prognostic importance of the cardiac MRI finding of right ventricular involvement in patients with acute ST-segment elevation myocardial infarction (MI). SUBJECTS AND METHODS: Fifty patients (41 men, nine women; mean age, 58 +/- 11 years) with first-ST-segment elevation MI underwent 1.5-T cardiac MRI immediately after successful percutaneous coronary intervention. The cardiac MRI protocol included steady-state free precession cine sequences for functional assessment of the left, right, and both ventricles and inversion recovery FLASH delayed enhancement sequences after contrast administration for the quantification of myocardial damage. The prevalence of right ventricular involvement detected with ECG and echocardiography was compared with the prevalence detected with cardiac MRI, which was the reference standard. Patients underwent follow-up for 32 +/- 8 months.
RESULTS: Right ventricular involvement was diagnosed with cardiac MRI in 27 patients (54%): 14 of 30 patients (47%) with inferior ST-segment elevation MI and 13 of 20 patients (65%) with anterior ST-segment elevation MI. ECG and echocardiographic findings showed only moderate agreement with cardiac MRI findings in the detection of right ventricular involvement in inferior acute MI (kappa = 0.38). Patients with right ventricular involvement in anterior ST-segment elevation MI had larger infarcts (delayed enhancement, 25.9% +/- 14.5% vs 11.4% +/- 10.1%; p = 0.030), lower left ventricular ejection fraction (34.3% +/- 8.2% vs 45.2% +/- 9.5%; p < 0.015), and lower right ventricular ejection fraction (39.8% +/- 6.6% vs 54.9% +/- 8.8%; p < 0.001) than those without right ventricular involvement. In a multivariate logistic regression model, right ventricular involvement was a strong independent predictor (odds ratio, 15.8; 95% CI, 4-63%) of major cardiac adverse events.
CONCLUSION: Right ventricular involvement in ST-segment elevation MI is detected more frequently with cardiac MRI than with ECG and echocardiography and is an independent prognostic indicator.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20173133     DOI: 10.2214/AJR.09.2829

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  21 in total

1.  Echocardiographic assessment of global longitudinal right ventricular function in patients with an acute inferior ST elevation myocardial infarction and proximal right coronary artery occlusion.

Authors:  Martin Hutyra; Tomáš Skála; David Horák; Martin Köcher; Zbyněk Tüdös; Jana Zapletalová; Jan Přeček; Albert Louis; Aleš Smékal; Miloš Táborský
Journal:  Int J Cardiovasc Imaging       Date:  2014-11-18       Impact factor: 2.357

2.  Primary reperfusion in acute right ventricular infarction: An observational study.

Authors:  Eulo Lupi-Herrera; Héctor González-Pacheco; Ursulo Juárez-Herrera; Nilda Espinola-Zavaleta; Eduardo Chuquiure-Valenzuela; Ramón Villavicencio-Fernández; Marco Antonio Peña-Duque; Ernesto Ban-Hayashi; Sergio Férez-Santander
Journal:  World J Cardiol       Date:  2014-01-26

3.  Impact of hyperglycemia at admission in patients with acute ST-segment elevation myocardial infarction as assessed by contrast-enhanced MRI.

Authors:  Christoph J Jensen; Holger C Eberle; Kai Nassenstein; Thomas Schlosser; Mani Farazandeh; Christoph K Naber; Georg V Sabin; Oliver Bruder
Journal:  Clin Res Cardiol       Date:  2011-02-24       Impact factor: 5.460

4.  Utility of cardiac magnetic resonance (CMR) in the evaluation of right ventricular (RV) involvement in patients with myocardial infarction (MI).

Authors:  Nicola Galea; Marco Francone; Iacopo Carbone; David Cannata; Francesco Vullo; Roberto Galea; Luciano Agati; Francesco Fedele; Carlo Catalano
Journal:  Radiol Med       Date:  2013-12-12       Impact factor: 3.469

5.  The impact of right ventricular function assessed by 2-dimensional speckle tracking echocardiography on early mortality in patients with inferior myocardial infarction.

Authors:  Batur G Kanar; Mustafa K Tigen; Murat Sunbul; Altug Cincin; Halil Atas; Alper Kepez; Beste Ozben
Journal:  Clin Cardiol       Date:  2018-03-25       Impact factor: 2.882

6.  Assessment of right ventricular functional recovery after acute myocardial infarction by 2D speckle-tracking echocardiography.

Authors:  Olivier Huttin; Jérémie Lemarié; Marine Di Meglio; Nicolas Girerd; Damien Mandry; Frédéric Moulin; Simon Lemoine; Yves Juillière; Jacques Felblinger; Pierre-Yves Marie; Christine Selton-Suty
Journal:  Int J Cardiovasc Imaging       Date:  2015-01-06       Impact factor: 2.357

7.  Angiographic result of index PCI determines the presence of right ventricular infarction in patients with acute inferior myocardial infarction.

Authors:  Marek Tomala; Tomasz Miszalski-Jamka; Wojciech Zajdel; Bartłomiej Nawrotek; Wojciech Mazur; Dean J Kereiakes; Krzysztof Zmudka
Journal:  Int J Cardiovasc Imaging       Date:  2015-07-25       Impact factor: 2.357

Review 8.  The challenges in the management of right ventricular infarction.

Authors:  Taku Inohara; Shun Kohsaka; Keiichi Fukuda; Venu Menon
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2013-09

9.  The role of cardiac magnetic resonance in the evaluation of patients presenting with suspected or confirmed acute coronary syndrome.

Authors:  Loren P Budge; Michael Salerno
Journal:  Cardiol Res Pract       Date:  2011-10-19       Impact factor: 1.866

10.  Right ventricular involvement in anterior myocardial infarction: a tissue Doppler-derived strain and strain rate study.

Authors:  Osman Sonmez; Mehmet Kayrak; Gokhan Altunbas; Turyan Abdulhalikov; Yusuf Alihanoglu; Ahmet Bacaksiz; Kurtulus Ozdemir; Hasan Gok
Journal:  Clinics (Sao Paulo)       Date:  2013-09       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.